Successful treatment of ulcerative necrobiosis lipoidica with JAK inhibitor.

Clicks: 202
ID: 95642
2020
Article Quality & Performance Metrics
Overall Quality Improving Quality
0.0 /100
Combines engagement data with AI-assessed academic quality
AI Quality Assessment
Not analyzed
Abstract
Necrobiosis lipoidica (NL) is a rare granulomatous disease that predominantly affects middle aged women and is often associated with diabetes mellitus and other metabolic disorders . About 30 % of the patients develop ulcerations within NL lesions on the lower leg, which complicate the course of disease and are often recalcitrant to standard wound care procedures . Systemic therapies for NL are reported only for single cases or in small case series with varying outcome . Randomized controlled trials are missing due to the character of NL as an orphan disease.
Reference Key
erfurtberge2020successfuljournal Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Erfurt-Berge, C;Sticherling, M;
Journal journal of the european academy of dermatology and venereology : jeadv
Year 2020
DOI
10.1111/jdv.16297
URL
Keywords
jak inhibitor granulomatous disorder leg ulcer necrobiosis lipoidica

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.